文献速递咽喉与嗓音

声带瘢痕门诊内类固醇注射后改善的相关因素

Factors Associated With Improvement Following In-office Steroid Injections for Vocal Fold Scar.
PubMed 文献 · Laryngoscope · 2024-09-12

单中心研究纳入2013至2024年接受门诊内声带类固醇注射的声带瘢痕患者,22例有注射后1-3个月随访数据;VHI-10中位下降4分(p=0.02),但黏膜波与振幅改善者仅45%,且距声带损伤时间较短与左侧声带振动参数改善相关(p=0.03)。

要点

  • 门诊内声带类固醇注射后VHI-10中位下降4分(p=0.02),患者报告声音使用有适度改善。
  • 随访时倒谱峰值突出(CPP)与基频变异系数(F0CoV)无差异。
  • 45%患者至少一侧声带黏膜波和振幅改善,距声带损伤时间较短与左侧声带改善相关(p=0.03)。

核心结论

  • 门诊内声带类固醇注射后患者报告声音使用有适度改善,但作者认为其效果可能不如既往所认为的那样显著。
  • 视频喉镜下的振动参数改善预计见于约半数患者,距声带损伤时间较短可能是成功的预测因素。
  • 这些部分阴性的结果有助于向患者说明门诊内声带类固醇注射的获益。

研究设计与样本

  • 单中心研究,评估2013年至2024年接受门诊内声带类固醇注射的声带瘢痕患者。
  • 22例患者有类固醇注射后1-3个月的随访数据。
  • 采用Wilcoxon符号秩检验和McNemar检验分析注射前后VHI-10评分、频闪喉镜振动参数、持续发声时倒谱峰值突出(CPP)和基频变异系数(F0CoV)。

主要发现

  • 一次注射后VHI-10中位下降4分(p=0.02)。
  • 随访时CPP和F0CoV测量值无差异。
  • 45%患者至少一侧声带的黏膜波和振幅改善。
  • 距声带损伤时间较短与左侧声带黏膜波和振幅改善相关(p=0.03)。
  • 振动参数改善者与未改善者之间在性别、吸烟史、歌唱状态、次要诊断和基线VHI-10评分方面无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aims to evaluate the clinical outcomes of patients receiving in-office vocal fold steroid injections (VFSI), highlighting relatively new measures around vocal pitch. METHODS: Patients with a diagnosis of vocal fold scar who received in-office VFSI from 2013 to 2024 were evaluated. Pre- and post-steroid Voice Handicap Index (VHI-10) scores, stroboscopic vibratory parameters, acoustic measures of cepstral peak prominence (CPP), and fundamental frequency coefficient of variation (F0CoV) during sustained phonation were analyzed using Wilcoxon signed-rank tests and McNemar's tests. RESULTS: Twenty-two patients had follow-up data 1-3 months after steroid injection. The median decrease in VHI-10 after one injection was 4 points (p = 0.02). We found no difference in CPP and F0CoV measures at follow-up. Forty-five percent of patients improved in mucosal wave and amplitude of at least one vocal fold. Earlier presentation from vocal injury was associated with improvement in mucosal wave and amplitude of the left vocal fold (p = 0.03). We found no difference in sex, tobacco smoking history, singing status, secondary diagnosis, and baseline VHI-10 score between patients who improved in vibratory parameters and those who did not. CONCLUSION: This single-center study is one of the largest exploring patient outcomes following in-office VFSI. Though patients reported modest improvement in voice use after VFSI, this may not be as impactful as previously believed. Improvement in videostroboscopy is expected in about half of the patients, with recency from vocal injury a likely predictor of success. These partially negative results provide insight into counseling patients regarding benefits from in-office VFSI. LEVEL OF EVIDENCE: 4 Laryngoscope, 135:227-233, 2025.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Tesema N, Lackey TG, O'Connor M, et al. Factors Associated With Improvement Following In-office Steroid Injections for Vocal Fold Scar. Laryngoscope. 2024. PMID: 39264157. doi:10.1002/lary.31734

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。